D-1058-2014 Class III Terminated

Recalled by Pfizer Inc. — New York, NY

FDA drug recall D-1058-2014 was initiated by Pfizer Inc. on Nov 4, 2013 and is designated Class III. Reason for recall: Failed Dissolution Specification; 8 hr stability timepoint The recall status is terminated (terminated Jun 24, 2015). Affected quantity: 14,357 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 12, 2014
Initiation Date
Nov 4, 2013
Termination Date
Jun 24, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,357 bottles

Product description

Glucotrol XL (glipizide) extended release tablets, 5 mg, 100 count bottles, Rx only, Distributed by Roerig, Division of Pfizer Inc, NY, NY --- NDC 0049-1550-66

Reason for recall

Failed Dissolution Specification; 8 hr stability timepoint

Distribution pattern

US nationwide (including PR)

Code information

Lot V120131

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1058-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1058-2014. Report a data issue: hello@regdatalab.com.